Polymorphisms in RETN gene and susceptibility to colon cancer in Saudi patients

BACKGROUND AND OBJECTIVES: Resistin is an adipocytokine, which has been studied for its role in insulin resistance and recently in inflammation. Several single-nucleotide polymorphisms (SNPs) have been identified in the human resistin gene (RETN). This study aims to investigate the association of RE...

Full description

Bibliographic Details
Main Author: Rowyda N. Alharithy
Format: Article
Language:English
Published: King Faisal Specialist Hospital and Research Centre 2014-07-01
Series:Annals of Saudi Medicine
Online Access:https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2014.334
_version_ 1819172495109914624
author Rowyda N. Alharithy
author_facet Rowyda N. Alharithy
author_sort Rowyda N. Alharithy
collection DOAJ
description BACKGROUND AND OBJECTIVES: Resistin is an adipocytokine, which has been studied for its role in insulin resistance and recently in inflammation. Several single-nucleotide polymorphisms (SNPs) have been identified in the human resistin gene (RETN). This study aims to investigate the association of RETN rs1862513 (C-420G) and rs3745367 (G+299A) SNPs with the colon cancer risk in Saudi patients. DESIGN AND SETTINGS: This is a case-control study conducted among Saudi adult colon cancer patients recruited from King Abdulaziz Hospital and Oncology Center in Jeddah, Saudi Arabia. SUBJECTS AND METHODS: In this study, 120 Saudi volunteers (60 colon cancer patients and 60 disease-free controls) were studied. The SNPs were determined by polymerase chain reaction (PCR) and genotyping using PCR- restriction fragment length polymorphism analysis. RESULTS: In comparing the result obtained for the patient group with that of the controls, colon cancer group displayed different genotype distribution of the RETN C-420G and G+299A SNPs. The study indicated that the SNP-420 heterozygous (CG) genotype (odds ratio [OR]=2.48, 95% CI 1.07–5.74, P=.03) and the SNP +299 heterozygous (GA) genotype (OR=6.5, 95% CI 1.77–24.18, P=.002) significantly increased the risk of colon cancer. A further analysis of the genotype combination of SNPs RETN C-420G and G+299A showed a larger increase in the colon cancer risk. CONCLUSION: These preliminary results suggested a potential role for RETN C-420G and G+299A polymorphisms in the genetic predisposition to colon cancer disease.
first_indexed 2024-12-22T20:08:05Z
format Article
id doaj.art-22bf51c323bc46f99bc9656d83b19700
institution Directory Open Access Journal
issn 0256-4947
0975-4466
language English
last_indexed 2024-12-22T20:08:05Z
publishDate 2014-07-01
publisher King Faisal Specialist Hospital and Research Centre
record_format Article
series Annals of Saudi Medicine
spelling doaj.art-22bf51c323bc46f99bc9656d83b197002022-12-21T18:14:06ZengKing Faisal Specialist Hospital and Research CentreAnnals of Saudi Medicine0256-49470975-44662014-07-0134433433910.5144/0256-4947.2014.334asm-4-334Polymorphisms in RETN gene and susceptibility to colon cancer in Saudi patientsRowyda N. Alharithy0From the Department of Biochemistry, King Abdulaziz University, Jeddah, Saudi ArabiaBACKGROUND AND OBJECTIVES: Resistin is an adipocytokine, which has been studied for its role in insulin resistance and recently in inflammation. Several single-nucleotide polymorphisms (SNPs) have been identified in the human resistin gene (RETN). This study aims to investigate the association of RETN rs1862513 (C-420G) and rs3745367 (G+299A) SNPs with the colon cancer risk in Saudi patients. DESIGN AND SETTINGS: This is a case-control study conducted among Saudi adult colon cancer patients recruited from King Abdulaziz Hospital and Oncology Center in Jeddah, Saudi Arabia. SUBJECTS AND METHODS: In this study, 120 Saudi volunteers (60 colon cancer patients and 60 disease-free controls) were studied. The SNPs were determined by polymerase chain reaction (PCR) and genotyping using PCR- restriction fragment length polymorphism analysis. RESULTS: In comparing the result obtained for the patient group with that of the controls, colon cancer group displayed different genotype distribution of the RETN C-420G and G+299A SNPs. The study indicated that the SNP-420 heterozygous (CG) genotype (odds ratio [OR]=2.48, 95% CI 1.07–5.74, P=.03) and the SNP +299 heterozygous (GA) genotype (OR=6.5, 95% CI 1.77–24.18, P=.002) significantly increased the risk of colon cancer. A further analysis of the genotype combination of SNPs RETN C-420G and G+299A showed a larger increase in the colon cancer risk. CONCLUSION: These preliminary results suggested a potential role for RETN C-420G and G+299A polymorphisms in the genetic predisposition to colon cancer disease.https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2014.334
spellingShingle Rowyda N. Alharithy
Polymorphisms in RETN gene and susceptibility to colon cancer in Saudi patients
Annals of Saudi Medicine
title Polymorphisms in RETN gene and susceptibility to colon cancer in Saudi patients
title_full Polymorphisms in RETN gene and susceptibility to colon cancer in Saudi patients
title_fullStr Polymorphisms in RETN gene and susceptibility to colon cancer in Saudi patients
title_full_unstemmed Polymorphisms in RETN gene and susceptibility to colon cancer in Saudi patients
title_short Polymorphisms in RETN gene and susceptibility to colon cancer in Saudi patients
title_sort polymorphisms in retn gene and susceptibility to colon cancer in saudi patients
url https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2014.334
work_keys_str_mv AT rowydanalharithy polymorphismsinretngeneandsusceptibilitytocoloncancerinsaudipatients